home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

23.02 -0.46 (-1.96%)

Official Closing Price Updated: 7:00 PM EST, Feb 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

49 50 Next >

Hims & Hers Health Unusual Options Activity For February 03 ↗

February 03, 2025

Via Benzinga

Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio? ↗

February 02, 2025

Check out this week's top-performing mid-cap stocks, including Akero Therapeutics' remarkable 106.57% surge following positive clinical trial results and other companies like Surgery Partners...

Via Benzinga

Unlocking the Growth Potential of NYSE:HIMS. ↗

January 31, 2025

A fundamental analysis of (NYSE:HIMS): Is HIMS & HERS HEALTH INC (NYSE:HIMS) suited for growth investing?

Via Chartmill

Is Hims & Hers Health Stock a Buy? ↗

January 28, 2025

Here's a look into one of healthcare's hottest growth stocks.

Via The Motley Fool

Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play

January 22, 2025

GLP-1 drugs have been all the rage for weight loss, but GE Healthcare and Novo Nordisk are working on a non-invasive approach to controlling metabolic functions

Via MarketBeat

Hims & Hers Health Unusual Options Activity ↗

January 21, 2025

Via Benzinga

Why the high growth investor may take a look at NYSE:HIMS. ↗

January 20, 2025

Unlocking the high Growth Potential of HIMS & HERS HEALTH INC (NYSE:HIMS).

Via Chartmill

Is Hims & Hers Stock in Trouble? ↗

January 16, 2025

Via The Motley Fool

8 Health Care Stocks Whale Activity In Today's Session ↗

January 20, 2025

Via Benzinga

Hims & Hers Health: A Stock to Trade or Own?

January 20, 2025

HIMS achieved remarkable growth in 2024 but now faces challenges in 2025, raising the question of whether it suits traders better than long-term investors.

Via MarketBeat

Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today ↗

January 17, 2025

Via The Motley Fool

Top Growth Picks: 3 Low-Cost Stocks That Could Double in Value

January 17, 2025

Here are three low-priced stocks you can buy today that are positioned in sector that make them solid choices to double in 2025

Via MarketBeat

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 14, 2025

Via Benzinga

Evaluating NYSE:HIMS for Growth Investment Opportunities. ↗

January 10, 2025

Is HIMS & HERS HEALTH INC (NYSE:HIMS) suited for growth investing?

Via Chartmill

What 12 Analyst Ratings Have To Say About Hims & Hers Health ↗

January 06, 2025

Via Benzinga

Hims & Hers Stock Is Poised for a Major Surge in 2025 ↗

January 10, 2025

The focus is on GLP-1s, but there's more to Hims & Hers than one product.

Via The Motley Fool

What's Going On With Hims & Hers Health Stock? ↗

January 09, 2025

Hims & Hers reported impressive third-quarter results in November, with earnings of 32 cents per share, far exceeding analyst expectations.

Via Benzinga

Stock Picks 2024 Year In Review ↗

January 01, 2025

Unlike 2023, 2024 was a very concentrated year, with just a few key large-cap stocks driving much of the index's returns.

Via Talk Markets

Topics Stocks / Equities

Is Hims & Hers Health a Millionaire Maker? ↗

January 01, 2025

Arguments are piling up for why the company might fail, but the business continues to deliver strong results.

Via The Motley Fool

3 Hot Stocks That Can Double Again in 2025 ↗

December 31, 2024

Three unlikely winners of 2024 can lead the way in the year ahead.

Via The Motley Fool

Prediction: This Will Be Amazon's Next Big Acquisition ↗

December 27, 2024

Amazon may be known for its retail and tech chops, but the company has also built a strong operation in the healthcare realm over the last several years.

Via The Motley Fool

Is NYSE:HIMS suited for growth investing? ↗

December 19, 2024

HIMS & HERS HEALTH INC (NYSE:HIMS) may be suited for growth investing, we'll explore why in this article.

Via Chartmill

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 26, 2024

Via Benzinga

Will The Falling Hims & Hers Stock Price Recover In 2025? ↗

December 22, 2024

Hims & Hers share price has crashed by over 20% this year after an unfavorable FDA ruling.

Via Talk Markets

Topics Stocks / Equities

Hims & Hers Stock: Growth, Noise, and Where to Focus Now ↗

December 20, 2024

Hims & Hers stock is full of noise, but what's the signal for investors?

Via The Motley Fool

Hims & Hers Health Are Falling Today: What's Going On? ↗

December 19, 2024

Hims & Hers Health, Inc. (NYSE: HIMS) are trading lower Thursday. The U.S. Food and Drug Administration (FDA) issued a new decision regarding the status of tirzepatide injection shortages, which have...

Via Benzinga

From Powell To Profits: Strategic Stock Picks Amid Market Uncertainty ↗

December 19, 2024

Yesterday's market movement aligned perfectly with expectations, as the FOMC meeting drove significant volatility.

Via Talk Markets

Topics Stocks / Equities

IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List ↗

December 19, 2024

Compounders now have until late March to wind down their operations, depending on their licensing.

Via Investor's Business Daily

This Is Huge News for Eli Lilly Investors ↗

December 19, 2024

Eli Lilly just gave investors several reasons to cheer.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 18, 2024

Via Benzinga

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

49 50 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com